Addus HomeCare Corporation (ADUS)
NASDAQ: ADUSHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ADUS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.28B
- P/E (TTM)
- 20.38
- Forward P/E
- 16.12
- EPS (TTM)
- $6.01
- Dividend yield
- None
- 52-week range
- 87.95 – 131.59
- Day range
- 119.26 – 123.29
- Volume / Avg
- 254.34K / 220.25K
- Beta
- —
- Shares outstanding
- 18.63M
52-week range
ADUS stock today
Shares of Addus HomeCare (ADUS) finished higher on Nov 20 at $122.50, a gain of 1.18% or $1.43 per share, versus the S&P 500's 3.70% decline. Shares are 6.9% below their 52-week high of $131.59, set on Nov 5, 2026 and 39.3% above the 52-week low of $87.95, in the middle of the past year's range. ADUS is up 14.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 8.7%.
At 20.4x trailing earnings, Addus HomeCare trades below the peer-group median of 65.3x. Its forward P/E of 16.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Addus HomeCare
Company profileAddus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. R. Dirk Allison CPA
- Headquarters
- Frisco, TX
- Employees
- 5,982
- IPO year
- 2009
- Website
- addus.com
Financial highlights
Full financialsIn fiscal 2025, Addus HomeCare generated $1.42 billion in revenue, up 23.2% from fiscal 2024, its 15th consecutive year of revenue growth. Net income was $95.9 million (+30.3% year over year), for a net margin of 6.7% versus a median of 5.2% in the prior 5 years. Gross margin was 32.5% (flat year over year) and operating margin 9.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.42B | $1.15B | $1.06B | $951.12M | $864.50M |
| Growth | +23.21% | +9.06% | +11.31% | +10.02% | +13.04% |
| Net income | $95.91M | $73.60M | $62.52M | $46.02M | $45.13M |
| EPS (diluted) | $5.22 | $4.23 | $3.83 | $2.84 | $2.81 |
Analyst forecast
ForecastConsensus (14 analysts)
buy
Avg. price target
$141.46+15.48%
- Strong buy 3
- Buy 8
- Hold 2
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $1.38 vs $1.61
- Surprise
- -14.29%
ADUS news
All ADUS news- ADUS or ELAN: Which Is the Better Value Stock Right Now?NasdaqADUS, ELAN
- Are Medical Stocks Lagging Cardinal Health (CAH) This Year?NasdaqCAH, ADUS
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to WatchNasdaqADUS, HIMS, BKD, AVAH
- Addus HomeCare (ADUS) Q3 2026 Earnings Call TranscriptNasdaq
- Addus HomeCare Corporation Reports Third Quarter 2026 Net Service Revenues of $387.7 MillionNasdaq
- Addus HomeCare Non-GAAP EPS of $1.83 beats by $0.04, revenue of $387.7M misses by $0.99MSeeking Alpha
- Addus HomeCare Announces Third Quarter 2026 Financial ResultsBusiness Wire
- Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat EstimatesNasdaqDGX, ADUS
Addus HomeCare peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AVAHAveanna Healthcare Holdings Inc. | 11.01 | +2.90% | $2.40B | vs ADUS |
| USPHU.S. Physical Therapy Inc. | 95.93 | +1.71% | $1.43B | vs ADUS |
| WGSGeneDx Holdings Corp. Class A | 45.46 | -7.68% | $1.36B | vs ADUS |
| TDOCTeladoc Health Inc. | 7.45 | -4.36% | $1.36B | vs ADUS |
| PRVAPrivia Health Group Inc. | 25.05 | +1.46% | $3.20B | vs ADUS |
| INNVInnovAge Holding Corp. | 9.16 | +2.81% | $1.25B | vs ADUS |
| PNTGThe Pennant Group Inc. | 34.64 | +1.61% | $1.22B | vs ADUS |
| HIMSHims & Hers Health Inc. Class A | 14.60 | -8.86% | $3.42B | vs ADUS |
Indexes, lists and sector
Addus HomeCare stock FAQ
What is Addus HomeCare's stock price today?
ADUS last traded at $122.50 as of Nov 20, 4:00 PM EST, up 1.18% on the day. Prices are delayed at least 15 minutes.
What is ADUS's P/E ratio?
ADUS trades at a trailing P/E ratio of 20.38 and a forward P/E of 16.12, compared with a median of 65.3 for its closest peers.
Who is Addus HomeCare's CEO?
Mr. R. Dirk Allison CPA is the chief executive officer of Addus HomeCare Corporation, which has about 5,982 employees.
What is the ADUS 52-week high?
The 52-week high for ADUS is $131.59 and the 52-week low is $87.95. The stock is currently 6.9% below its high.